Related Experiment Video
Updated: Apr 6, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
Medically important fungi respond to azole drugs: an update
Martin Zavrel1, Theodore C White1
1University of Missouri-Kansas City, School of Biological Sciences, Division of Cell Biology & Biophysics, 5007 Rockhill Road, BSB 404, Kansas City, MO 64110, USA.
Abstract:
The increased numbers of patients with compromised immune systems in the last three decades have increased the chances of life-threatening fungal infections. Numerous antifungal drugs have been developed in the last 20 years to treat these infections. The largest group, the azoles, inhibits the synthesis of fungal sterols. The use of these fungistatic azoles has subsequently led to the emergence of acquired azole resistance. The most common mechanisms that result in azole resistance include the overexpression or mutation of the azole target enzyme, and overexpression of drug transporters that are responsible for azole efflux from cells. Additional, less-frequent mechanisms have also been identified. Understanding azole resistance mechanisms is crucial for current antifungal treatment and for the future development of new treatment strategies.
Insights
Rising fungal infections in immunocompromised patients necessitate new antifungal strategies. Understanding azole resistance mechanisms, like target mutation and drug efflux, is key to developing effective treatments.
Area of Science:
- Medical Mycology
- Antimicrobial Resistance
- Drug Development
Background:
- Increased incidence of life-threatening fungal infections in immunocompromised patients over the past 30 years.
- Development of numerous antifungal drugs in the last 20 years, with azoles being the largest class.
- Azoles inhibit fungal sterol synthesis, leading to fungistatic effects.
Purpose of the Study:
- To review the mechanisms of acquired azole resistance in fungi.
- To highlight the importance of understanding these mechanisms for current and future antifungal therapies.
Main Methods:
- Literature review of antifungal drug development and resistance mechanisms.
- Analysis of common and less frequent mechanisms of azole resistance.
- Focus on target enzyme alterations and drug efflux pumps.
Main Results:
- Acquired azole resistance is a significant clinical challenge.
- Common resistance mechanisms include target enzyme overexpression/mutation and enhanced drug efflux.
- Less frequent resistance mechanisms have also been identified.
Conclusions:
- Understanding azole resistance is crucial for effective antifungal treatment.
- Knowledge of resistance mechanisms informs the development of novel antifungal strategies.
- Continued research is needed to combat emerging drug resistance.
Related Concept Videos
Antifungal Agents
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Fungal Phylum Microsporidia
Overview of Fungi
Fungal Phylum Basidiomycota

